Literature DB >> 2912249

Treatment of cocaine-induced panic disorder.

A K Louie1, R A Lannon, T A Ketter.   

Abstract

The authors describe 10 patients who developed panic attacks only after substantial cocaine use. The timing of the onset of symptoms, i.e., after 1-6 years of cocaine use, and the fact that only one patient had a first-degree relative with panic disorder were more suggestive of acquired than primary panic disorder. The patients' atypical symptoms and responses to medications may be explained in terms of limbic-neuronal hyperexcitability induced by cocaine through a kindling mechanism.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2912249     DOI: 10.1176/ajp.146.1.40

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  7 in total

1.  Animal model for investigating the anxiogenic effects of self-administered cocaine.

Authors:  A Ettenberg; T D Geist
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

Review 2.  Neurobiologic processes in drug reward and addiction.

Authors:  Bryon Adinoff
Journal:  Harv Rev Psychiatry       Date:  2004 Nov-Dec       Impact factor: 3.732

3.  Elevations of FosB in the nucleus accumbens during forced cocaine abstinence correlate with divergent changes in reward function.

Authors:  G C Harris; M Hummel; M Wimmer; S D Mague; G Aston-Jones
Journal:  Neuroscience       Date:  2007-06-07       Impact factor: 3.590

4.  Cocaine kindling in mice. Responses to N-methyl-D,L-aspartate (NMDLA) and L-arginine.

Authors:  Y Itzhak
Journal:  Mol Neurobiol       Date:  1995 Aug-Dec       Impact factor: 5.590

Review 5.  Dual diagnosis.

Authors:  M F Sheehan
Journal:  Psychiatr Q       Date:  1993

Review 6.  Pharmacologic approaches to the treatment of cocaine dependence.

Authors:  W A Taylor; M S Gold
Journal:  West J Med       Date:  1990-05

7.  Beta-adrenergic antagonists attenuate withdrawal anxiety in cocaine- and morphine-dependent rats.

Authors:  G C Harris; G Aston-Jones
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.